Urinary Incontinence (UI)SUPPORTNCT06798311
Reducing Disparities in Urinary Control Symptoms for Minority Women
A study testing SUPPORT workbook in people with Urinary Incontinence (UI) and Lower Urinary Tract Symptoms (LUTS), run by University of Chicago at 2 sites in United States.
Trial summary
The study is designed to address the disparity in available conservative/behavioral treatments for UI/LUTS. The program was developed by experts from urogynecology, psychology, and physical therapy then modified based on focus group feedback from racially minoritized women. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Urinary Incontinence (UI), Lower Urinary Tract Symptoms (LUTS), Pelvic Floor Disorder
- What is being tested?
- SUPPORT workbook
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 2 sitesUnited States
- Study dates
- 28 Oct 2024to May 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 18 years or older
- Able to converse in English
- A response of at least "somewhat bothered" by urinary incontinence, urinary frequency or urgency on the UDI
- Willing to engage in conservative treatment of their UI/LUTS for 16 weeks
Who cannot join
- Anterior or posterior pelvic organ prolapse beyond the hymen or apical prolapse to the hymen
- Currently taking medications for their UI/LUTS or history of surgical intervention for UI
- Patients with abnormal PVR and positive urine culture at time of study entry
- History of recurrent UTIs
- History of mobility or neurologic disorders that would prevent ability to complete at home physical therapy
- Planning to start PT within the next 16 weeks
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States2 sites, 2 recruiting
- Not yet recruiting
Northwestern University
Chicago, Illinois, 60611
Julia Geynisman-Tan, MD, 312-695-4623, Julia.Geynisman-Tan@nm.org
Oluwateniola Brown, MD
- Recruiting
The University of Chicago
Chicago, Illinois, 60637
Jinxuan Shi, MS, 773-795-2731, jinxuan.shi@bsd.uchicago.edu
Tara Samsel, BS, 7737952729, tara.samsel@bsd.uchicago.edu
About this study
The study is designed to address the disparity in available conservative/behavioral treatments for UI/LUTS. The program was developed by experts from urogynecology, psychology, and physical therapy then modified based on focus group feedback from racially minoritized women. The study team created a patient-centered, culturally adapted, self-directed, 8-week, home-based module for women with LUTS/UI. The SUPPORT program combines multiple evidence-based conservative treatments for LUTS/UI including cognitive behavioral therapy, behavioral modifications, and home physical therapy exercise. Progression through the home-based program is supported by research staff. This prospective interventional study aims to evaluate the feasibility and acceptability of the SUPPORT program and its impact on patient-centered treatment outcomes, while enabling comparisons across race and ethnicity. This approach will provide a comprehensive understanding of how to effectively deliver self-management strategies for pelvic floor disorders.
At the start of the 8 week SUPPORT course participants will also be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques and assisting patients in performing the SUPPORT exercises as outlined in the program. At the end of 8 weeks patients will fill out a survey assessing the frequency of use and interactions with the LLM.
Read the detailed description
Several recent large, population-based studies report that the prevalence of bothersome urinary incontinence (UI) and lower urinary tract symptoms (LUTS) ranges from 55-73%, and a woman's lifetime risk of surgery for pelvic floor disorders is 20%. In other words, one in every five women can expect to undergo surgery for UI or prolapse by age 80, underscoring the public health impact of these conditions. For perspective, a woman's lifetime risk of breast and lung cancer are 15% and 6%, respectively. Although the lifetime risk of UI/LUTS is significantly higher than that of breast cancer or lung cancer, UI/LUTS have not received the same level of attention by the public or the healthcare community, despite the severe consequences on quality of life. Women are often embarrassed to seek treatment and lack knowledge about how to manage these bothersome conditions. These barriers lead to reduced healthcare-seeking for these disorders, which further exacerbates the detrimental consequences for quality of life. Similarly, the study team recently found in a geographically diverse, population-based study that housing insecurity, unreliable transportation, housing insecurity, not having enough money to make ends meet, and percent federal poverty levels of 300% or less were associated with more LUTS and lower perceived bladder health.
Additionally, there are disparities in access to treatment for PFDs and inclusion in PFD research for racially minoritized women. One important disparity is the lack of access to evidence-based non-surgical options (e.g., diet and weight loss counseling, behavioral modification, physical therapy (PT), and cognitive behavioral therapy (CBT)) that should be recommended to most women because these treatments can treat multiple PFDs and restore quality of life without the need for more invasive approaches. These conservative interventions are often not offered to racially minoritized women due to poor access and coverage. Improving non-surgical treatment of bladder symptoms is crucial because treatments are complex and multidimensional; treating one symptom surgically can sometimes exacerbate other symptoms. Up to 6% of women who have surgery for stress urinary incontinence (SUI) will undergo a second surgery within 9 years. Women are also at increased risk for de novo urinary symptoms (urinary incontinence and urinary tract infection) after surgical interventions. Likewise, bladder symptoms lead to emotional distress (i.e., anxiety and depression), and in turn, emotional distress can exacerbate UI/LUTS. In order to prevent this cycle of cumulative symptoms and distress, environmental barriers to LUTS must be reduced, and publicly-insured women of low socio-economic status should be able to have the same access to non-surgical interventions as privately insured women.
Pelvic floor physical therapy (PFPT) is a well-established first-line treatment for UI/LUTS. A 2014 Cochrane Review, which included 21 trials with 1281 incontinent women, compared pelvic floor muscle exercises to sham or control treatments. Patients who performed pelvic floor muscle exercises were 17 times more likely to be cured or improved. Standard pelvic floor physical therapy, which combines behavioral retraining and manual muscle therapy, takes 8-12 sessions and requires insurance coverage, copays, travel, a significant time commitment, and effective communication with the therapist. Although some hospitals employ pelvic floor physical therapists, most operate within private practices and do not work with Medicaid or Medicare payers. Likely as a result of these disparities, prior studies have found that racially minoritized women are more likely to assume that surgery is the only treatment option for PFDs.
This study is designed to address the disparity in available conservative/behavioral treatments for UI/LUTS. The investigators created a patient-centered, culturally adapted, self-directed, 8-week, home-based module for women with LUTS/UI. The SUPPORT program combines multiple evidence-based conservative treatments for LUTS/UI, including cognitive behavioral therapy, behavioral modifications, and home physical therapy exercises. The program was developed by experts from urogynecology, psychology, and physical therapy, and then modified based on focus group feedback from racially minoritized women. The inclusion of women from all races and ethnicities in the study will allow for comparisons across groups, providing the fullest understanding of how to deliver effective self-management for pelvic floor disorders. Progression through the home-based program is supported by research staff. The aim of this prospective interventional study is to assess the feasibility and acceptability of the SUPPORT program and its impact on patient-centered treatment outcomes.
The SUPPORT workbook follows a template for how pelvic floor physical therapy is delivered in the typical in-person setting with a combination of education, bladder re-training exercises, pelvic floor stretching, and core strengthening. The educational topics were chosen by consensus among the clinical experts as the most common and important clinical contributors to UI/LUTS symptoms and common areas of patient misinformation.
To aid in the demonstration of physical therapy exercises, the workbook includes QR-coded links to videos of a physical therapist performing the exercises in an ideal form. The videos include audio instruction to ensure that patients can learn the concepts in either visual, auditory, or written form.
Recognizing the limited time that patients have to engage with this intervention and mimicking the time commitment of standard pelvic floor PT, the investigators aimed to have the program take no more than 2 hours per week. This time commitment is split between time dedicated to reading the chapter, time spent completing the physical therapy or cognitive behavioral therapy exercises on a daily basis, and the time spent engaging in physical activity of the patient's choosing. Patients are counseled that exercise is important to the program as it improves core strength, pelvic floor mobility, bowel motility, and behavioral activation while reducing anxiety.
The cognitive behavioral therapy (CBT) portion of the workbook is adapted from the standardized CBT protocol and includes short introductions and exercises pertaining to cognitive flexibility, behavioral activation, and social support.
Recent advances in artificial intelligence, particularly in the development of large language models (LLMs), have opened new possibilities in healthcare. The investigators also aim to explore the use of a customized LLM-based health coach to assist women participating in the SUPPORT program. By providing real-time support and guidance, the AI health coach could help overcome barriers to care and keep patients engaged in the treatment. This approach has the potential to enhance the effectiveness of self-management programs for pelvic floor disorders, making care more accessible and helping more women achieve better health outcomes.
Major goals of the study include:
Aim 1. To use a human-centered, iterative approach with qualitative interviews to create and adapt a self-managed CBT (SM-CBT) intervention along with a self-directed behavioral modification/PT (Home PT) program for women with UI/LUTS from all races and ethnicities, including those who are minority, low-income, and publicly insured.
Aim 2. To determine the efficacy of the SUPPORT intervention on UI/LUTS outcomes as well as patient acceptability and adherence.
Aim 3. To evaluate a large language model-based digital coach's ability to be integrated into a self-managed pelvic floor program.
- Being tested
- SUPPORT workbook
- Keywords
- cognitive behavioral therapy, self-directed, physical therapy, behavioral modifications, pelvic floor, home-based, health disparities
- Medical subject headings
- Urinary Incontinence, Lower Urinary Tract Symptoms, Pelvic Floor Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SUPPORT workbookBehavioural
Also called cognitive behavior therapy
The SUPPORT workbook contains a template for how pelvic floor physical therapy is delivered in the typical in-person setting with a combination of education, bladder re-training exercises, pelvic floor stretching and core strengthening. To aid in the demonstration of physical therapy exercises, the workbook includes QR-coded links to videos of a physical therapist performing the exercises in an ideal form. The videos include audio instruction to ensure that patients can learn the concepts in either visual, auditory or written form. The cognitive behavioral therapy (CBT) portion of the workbook is adapted from the standardized CBT protocol and includes short introductions and exercises pertaining to cognitive flexibility, behavioral activation and social support. The total time commitment for the program is 2-hours per week.
Patients also will be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques.
| Study group | Role | What they receive |
|---|---|---|
| SUPPORT workbook | Experimental | All enrolled patients will be given access to the SUPPORT workbook (hard copy and PDF). The SUPPORT workbook contains a template for how pelvic floor physical therapy is delivered in the typical in-person setting with a combination of education, bladder re-training exercises, pelvic floor stretching and core strengthening. Patients also will be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques and assisting patients in performing the SUPPORT exercises as outlined in the program. Receives: Behavioral: SUPPORT workbook |
What is being measured
The primary outcome is the main question the study is designed to answer.
Urinary Symptom Changes (UDI Subscale)
To compare changes in urinary symptoms using the validated Urinary Distress Inventory (UDI) subscale of the Pelvic Floor Distress Inventory (PFDI) between baseline and 8-weeks (program completion) in patients undergoing the SUPPORT program. The Urinary Distress Inventory (UDI-6) is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women. The UDI-6 score is calculated by averaging the responses to each question (possible value 0 to 4), then multiplying that average by 25 to scale the score from 0 to 100. A higher score indicates greater distress.
Measured: From enrollment to the end of treatment at 8 weeks
Secondary outcomes (9)
Urinary symptoms - UDI-6 (16 Weeks)
To compare changes in urinary symptoms using the UDI between baseline and 16 weeks (2 months after program completion) after SUPPORT program initiation.
The Urinary Distress Inventory (UDI-6) is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women. The UDI-6 score is calculated by averaging the responses to each question (possible value 0 to 4), then multiplying that average by 25 to scale the score from 0 to 100. A higher score indicates greater distress.
Measured: From enrollment to 16 weeks after SUPPORT program initiation
Urinary symptoms - LURN SI-10 (16 Weeks)
To compare changes in urinary symptoms using the LURN SI-10 between baseline and 16 weeks (2 months after program completion) after SUPPORT program initiation.
LURN Symptom Index-10 (LURN SI-10) were developed as patient-reported outcome measures to assess urinary symptoms in adult men and women. Higher scores indicate greater severity of LUTS. Scores on the LURN SI-10 range from 0 (least severe) to 38 (most severe).
Measured: From enrollment to 16 weeks after SUPPORT program initiation
Patient Global Impression of Improvement (PGI-I)
To describe self-reported Patient Global Impression of Improvement (PGI-I) scores at 8 and 16 weeks after SUPPORT program initiation. The Patient global impression of improvement scale (PGI-I) is a single-item global rating of change scale that ask an individual patient to rate the severity of a specific condition. There are seven possible responses (scored 1-7): very much better, much better, a little better, no change, a little worse, much worse, and very much worse.
Measured: From enrollment to 16 weeks after SUPPORT program initiation
Pelvic Organ prolapse Distress Inventory and Colorectal-Anal distress Inventory subscales
To compare changes in prolapse and bowel symptoms using the Pelvic Organ prolapse Distress Inventory 6 (POPDI-6) and Colorectal-Anal distress Inventory 8 (CRAD-8) at 8 and 16 weeks after SUPPORT program initiation. Both are subscales within the validated PFDI-20 questionnaire, used to assess the severity of symptoms related to pelvic organ prolapse and bowel dysfunction, respectively.
Each subscale is calculated by obtaining the mean value of all of the answered items within the corresponding scale (possible value 0 to 4) and then multiplying by 25 to obtain the scale score (range 0 to 100).
Measured: From enrollment to 16 weeks after SUPPORT program initiation
Adherence
To describe patient adherence to SUPPORT program at 8- and 16 weeks after SUPPORT program initiation.
Adherence (at 8 weeks and 16 weeks after starting the program): How closely were you able to follow the SUPPORT program recommendations after starting the program? (Followed all recommendations; Followed most recommendations; Followed some recommendations; Rarely followed recommendations; Did not follow any recommendations).
Measured: From enrollment to 16 weeks after SUPPORT program initiation
Patient Satisfaction with the SUPPORT Program
To describe patient satisfaction to SUPPORT program at 8- and 16 weeks after SUPPORT program initiation.
Satisfaction (at 8 weeks after starting the program): How satisfied are you with the SUPPORT program? (Very satisfied; Satisfied; Neutral; Dissatisfied; Very dissatisfied).
Measured: From enrollment to 16 weeks after SUPPORT program initiation
PROMIS-57 - Patient Reported Outcomes Measurement Information System
To compare anxiety, depression, fatigue, pain, physical function, sleep disturbance, and social roles using the NIH Patient Reported Outcomes Measurement Information System (PROMIS-57) profile at 8- and 16-weeks after SUPPORT program initiation.
PROMIS-57 measures are scored on the T-score metric - in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. High scores mean more of the concept being measured (e.g., more Fatigue, more Physical Function).
Measured: From enrollment to 16 weeks after SUPPORT program initiation
Large Language Model usability (SUS - the System Usability Scale)
To evaluate a large language model based digital coach's ability to be integrated into a self managed pelvic floor program. The System Usability Scale (SUS) is a 10-item questionnaire that provides a single composite score representing the overall usability of the system being evaluated. SUS scores range from 0 to 100, with higher scores indicating greater usability.
Measured: From enrollment to the end of treatment at 8 weeks
Attitudes toward Large Language Model Use (WAI-TECH-SF - Working Alliance Inventory for Online Interventions-Short Form)
To assess patient satisfaction and attitudes toward use of a LLM as part of a self managed program. The Working Alliance Inventory for Online Interventions-Short Form (WAI-TECH-SF) is a 12-item self-report questionnaire that assess the therapeutic alliance between a patient and an online program. The scale ranges from 1 (never) to 5 (always). Higher scores indicate a stronger alliance.
Measured: From enrollment to the end of treatment at 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jan 2025
- Study start28 Oct 2024
- Primary completionMay 2027 (estimated)
- Study completionMay 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (25)Papers the sponsor has linked to this study.
- Other trials for Urinary Incontinence (UI)Studies of the same condition, open and under way.
- More trials run by University of ChicagoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Chicago
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Northwestern University
- Responsible party
- Sponsor
- Investigators
- Kimberly Kenton, MD, Principal investigator, University of ChicagoJames Griffith, PhD, Principal investigator, University of Chicago
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06798311
- Sponsor's protocol ID
- IRB24-1131
- Other IDs
- 5R01DK129849-04
- Acronym
- SUPPORT
- Status last verified
- Apr 2026
- First submitted
- 22 Jan 2025
- Last updated
- 7 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Zoorob D, Higgins M, Swan K, Cummings J, Dominguez S, Carey E. Barriers to Pelvic Floor Physical Therapy Regarding Treatment of High-Tone Pelvic Floor Dysfunction. Female Pelvic Med Reconstr Surg. 2017 Nov/Dec;23(6):444-448. doi: 10.1097/SPV.0000000000000401.
PubMed 28145917Clason C, Sterner-Stein K, Hirschman KB, Barg FK, Riegel B. Developing effective health coaches: Experience gained in a clinical trial of a health coach intervention. Patient Educ Couns. 2023 Mar;108:107592. doi: 10.1016/j.pec.2022.107592. Epub 2022 Dec 9.
PubMed 36516655Al-Anezi FM. Exploring the use of ChatGPT as a virtual health coach for chronic disease management. Learn Health Syst. 2024 Jan 11;8(3):e10406. doi: 10.1002/lrh2.10406. eCollection 2024 Jul.
PubMed 39036525Hegde N, Vardhan M, Nathani D, Rosenzweig E, Speed C, Karthikesalingam A, Seneviratne M. Infusing behavior science into large language models for activity coaching. PLOS Digit Health. 2024 Apr 2;3(4):e0000431. doi: 10.1371/journal.pdig.0000431. eCollection 2024 Apr.
PubMed 38564502Stade EC, Stirman SW, Ungar LH, Boland CL, Schwartz HA, Yaden DB, Sedoc J, DeRubeis RJ, Willer R, Eichstaedt JC. Large language models could change the future of behavioral healthcare: a proposal for responsible development and evaluation. Npj Ment Health Res. 2024 Apr 2;3(1):12. doi: 10.1038/s44184-024-00056-z.
PubMed 38609507Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014 Jan;123(1):141-148. doi: 10.1097/AOG.0000000000000057.
PubMed 24463674Yazdany T, Jakus-Waldman S, Jeppson PC, Schimpf MO, Yurteri-Kaplan LA, Ferzandi TR, Weber-LeBrun E, Knoepp L, Mamik M, Viswanathan M, Ward RM; American Urogynecologic Society. American Urogynecologic Society Systematic Review: The Impact of Weight Loss Intervention on Lower Urinary Tract Symptoms and Urinary Incontinence in Overweight and Obese Women. Female Pelvic Med Reconstr Surg. 2020 Jan/Feb;26(1):16-29. doi: 10.1097/SPV.0000000000000802.
PubMed 31860569Woodburn KL, Tran MC, Casas-Puig V, Ninivaggio CS, Ferrando CA. Compliance With Pelvic Floor Physical Therapy in Patients Diagnosed With High-Tone Pelvic Floor Disorders. Female Pelvic Med Reconstr Surg. 2021 Feb 1;27(2):94-97. doi: 10.1097/SPV.0000000000000732.
PubMed 31045618Sigurdardottir T, Steingrimsdottir T, Geirsson RT, Halldorsson TI, Aspelund T, Bo K. Can postpartum pelvic floor muscle training reduce urinary and anal incontinence?: An assessor-blinded randomized controlled trial. Am J Obstet Gynecol. 2020 Mar;222(3):247.e1-247.e8. doi: 10.1016/j.ajog.2019.09.011. Epub 2019 Sep 14.
PubMed 31526791Siddiqui NY, Ammarell N, Wu JM, Sandoval JS, Bosworth HB. Urinary Incontinence and Health-Seeking Behavior Among White, Black, and Latina Women. Female Pelvic Med Reconstr Surg. 2016 Sep-Oct;22(5):340-5. doi: 10.1097/SPV.0000000000000286.
PubMed 27171320Segal JL, Vassallo B, Kleeman S, Silva WA, Karram MM. Prevalence of persistent and de novo overactive bladder symptoms after the tension-free vaginal tape. Obstet Gynecol. 2004 Dec;104(6):1263-9. doi: 10.1097/01.AOG.0000147596.44421.72.
PubMed 15572487Rhodes RE, Fiala B. Building motivation and sustainability into the prescription and recommendations for physical activity and exercise therapy: the evidence. Physiother Theory Pract. 2009 Jul;25(5-6):424-41. doi: 10.1080/09593980902835344.
PubMed 19842866Markland AD, Richter HE, Fwu CW, Eggers P, Kusek JW. Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008. J Urol. 2011 Aug;186(2):589-93. doi: 10.1016/j.juro.2011.03.114.
PubMed 21684555Mandimika CL, Murk W, Mcpencow AM, Lake AG, Miller D, Connell KA, Guess MK. Racial Disparities in Knowledge of Pelvic Floor Disorders Among Community-Dwelling Women. Female Pelvic Med Reconstr Surg. 2015 Sep-Oct;21(5):287-92. doi: 10.1097/SPV.0000000000000182.
PubMed 26313495Kotarinos RK. Pelvic floor physical therapy in urogynecologic disorders. Curr Womens Health Rep. 2003 Aug;3(4):334-9.
PubMed 12844459
Study at a glance
From the registry record, last updated by the sponsor on 7 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reducing Disparities in Urinary Control Symptoms for Minority Women
- ClinicalTrials.gov ID
- NCT06798311
- Acronym / sponsor ID
- SUPPORT / IRB24-1131
- Keywords
- cognitive behavioral therapy, self-directed, physical therapy, behavioral modifications, pelvic floor, home-based, health disparities
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- University of ChicagoUniversity, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Northwestern University
- Study start
- 28 Oct 2024 (actual)
- Primary completion
- May 2027 (estimated)
- Study completion
- May 2027 (estimated)
- First posted
- 29 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study is designed to address the disparity in available conservative/behavioral treatments for UI/LUTS. The program was developed by experts from urogynecology, psychology, and physical therapy then modified based on focus group feedback from racially minoritized women. The study team created a patient-centered, culturally adapted, self-directed, 8-week, home-based module for women with LUTS/UI. The SUPPORT program combines multiple evidence-based conservative treatments for LUTS/UI including cognitive behavioral therapy, behavioral modifications, and home physical therapy exercise. Progression through the home-based program is supported by research staff. This prospective interventional study aims to evaluate the feasibility and acceptability of the SUPPORT program and its impact on patient-centered treatment outcomes, while enabling comparisons across race and ethnicity. This approach will provide a comprehensive understanding of how to effectively deliver self-management strategies for pelvic floor disorders.
At the start of the 8 week SUPPORT course participants will also be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques and assisting patients in performing the SUPPORT exercises as outlined in the program. At the end of 8 weeks patients will fill out a survey assessing the frequency of use and interactions with the LLM.
Detailed description
Several recent large, population-based studies report that the prevalence of bothersome urinary incontinence (UI) and lower urinary tract symptoms (LUTS) ranges from 55-73%, and a woman's lifetime risk of surgery for pelvic floor disorders is 20%. In other words, one in every five women can expect to undergo surgery for UI or prolapse by age 80, underscoring the public health impact of these conditions. For perspective, a woman's lifetime risk of breast and lung cancer are 15% and 6%, respectively. Although the lifetime risk of UI/LUTS is significantly higher than that of breast cancer or lung cancer, UI/LUTS have not received the same level of attention by the public or the healthcare community, despite the severe consequences on quality of life. Women are often embarrassed to seek treatment and lack knowledge about how to manage these bothersome conditions. These barriers lead to reduced healthcare-seeking for these disorders, which further exacerbates the detrimental consequences for quality of life. Similarly, the study team recently found in a geographically diverse, population-based study that housing insecurity, unreliable transportation, housing insecurity, not having enough money to make ends meet, and percent federal poverty levels of 300% or less were associated with more LUTS and lower perceived bladder health.
Additionally, there are disparities in access to treatment for PFDs and inclusion in PFD research for racially minoritized women. One important disparity is the lack of access to evidence-based non-surgical options (e.g., diet and weight loss counseling, behavioral modification, physical therapy (PT), and cognitive behavioral therapy (CBT)) that should be recommended to most women because these treatments can treat multiple PFDs and restore quality of life without the need for more invasive approaches. These conservative interventions are often not offered to racially minoritized women due to poor access and coverage. Improving non-surgical treatment of bladder symptoms is crucial because treatments are complex and multidimensional; treating one symptom surgically can sometimes exacerbate other symptoms. Up to 6% of women who have surgery for stress urinary incontinence (SUI) will undergo a second surgery within 9 years. Women are also at increased risk for de novo urinary symptoms (urinary incontinence and urinary tract infection) after surgical interventions. Likewise, bladder symptoms lead to emotional distress (i.e., anxiety and depression), and in turn, emotional distress can exacerbate UI/LUTS. In order to prevent this cycle of cumulative symptoms and distress, environmental barriers to LUTS must be reduced, and publicly-insured women of low socio-economic status should be able to have the same access to non-surgical interventions as privately insured women.
Pelvic floor physical therapy (PFPT) is a well-established first-line treatment for UI/LUTS. A 2014 Cochrane Review, which included 21 trials with 1281 incontinent women, compared pelvic floor muscle exercises to sham or control treatments. Patients who performed pelvic floor muscle exercises were 17 times more likely to be cured or improved. Standard pelvic floor physical therapy, which combines behavioral retraining and manual muscle therapy, takes 8-12 sessions and requires insurance coverage, copays, travel, a significant time commitment, and effective communication with the therapist. Although some hospitals employ pelvic floor physical therapists, most operate within private practices and do not work with Medicaid or Medicare payers. Likely as a result of these disparities, prior studies have found that racially minoritized women are more likely to assume that surgery is the only treatment option for PFDs.
This study is designed to address the disparity in available conservative/behavioral treatments for UI/LUTS. The investigators created a patient-centered, culturally adapted, self-directed, 8-week, home-based module for women with LUTS/UI. The SUPPORT program combines multiple evidence-based conservative treatments for LUTS/UI, including cognitive behavioral therapy, behavioral modifications, and home physical therapy exercises. The program was developed by experts from urogynecology, psychology, and physical therapy, and then modified based on focus group feedback from racially minoritized women. The inclusion of women from all races and ethnicities in the study will allow for comparisons across groups, providing the fullest understanding of how to deliver effective self-management for pelvic floor disorders. Progression through the home-based program is supported by research staff. The aim of this prospective interventional study is to assess the feasibility and acceptability of the SUPPORT program and its impact on patient-centered treatment outcomes.
The SUPPORT workbook follows a template for how pelvic floor physical therapy is delivered in the typical in-person setting with a combination of education, bladder re-training exercises, pelvic floor stretching, and core strengthening. The educational topics were chosen by consensus among the clinical experts as the most common and important clinical contributors to UI/LUTS symptoms and common areas of patient misinformation.
To aid in the demonstration of physical therapy exercises, the workbook includes QR-coded links to videos of a physical therapist performing the exercises in an ideal form. The videos include audio instruction to ensure that patients can learn the concepts in either visual, auditory, or written form.
Recognizing the limited time that patients have to engage with this intervention and mimicking the time commitment of standard pelvic floor PT, the investigators aimed to have the program take no more than 2 hours per week. This time commitment is split between time dedicated to reading the chapter, time spent completing the physical therapy or cognitive behavioral therapy exercises on a daily basis, and the time spent engaging in physical activity of the patient's choosing. Patients are counseled that exercise is important to the program as it improves core strength, pelvic floor mobility, bowel motility, and behavioral activation while reducing anxiety.
The cognitive behavioral therapy (CBT) portion of the workbook is adapted from the standardized CBT protocol and includes short introductions and exercises pertaining to cognitive flexibility, behavioral activation, and social support.
Recent advances in artificial intelligence, particularly in the development of large language models (LLMs), have opened new possibilities in healthcare. The investigators also aim to explore the use of a customized LLM-based health coach to assist women participating in the SUPPORT program. By providing real-time support and guidance, the AI health coach could help overcome barriers to care and keep patients engaged in the treatment. This approach has the potential to enhance the effectiveness of self-management programs for pelvic floor disorders, making care more accessible and helping more women achieve better health outcomes.
Major goals of the study include:
Aim 1. To use a human-centered, iterative approach with qualitative interviews to create and adapt a self-managed CBT (SM-CBT) intervention along with a self-directed behavioral modification/PT (Home PT) program for women with UI/LUTS from all races and ethnicities, including those who are minority, low-income, and publicly insured.
Aim 2. To determine the efficacy of the SUPPORT intervention on UI/LUTS outcomes as well as patient acceptability and adherence.
Aim 3. To evaluate a large language model-based digital coach's ability to be integrated into a self-managed pelvic floor program.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| SUPPORT workbook | Experimental | Behavioral: SUPPORT workbookAll enrolled patients will be given access to the SUPPORT workbook (hard copy and PDF). The SUPPORT workbook contains a template for how pelvic floor physical therapy is delivered in the typical in-person setting with a combination of education, bladder re-training exercises, pelvic floor stretching and core strengthening. Patients also will be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques and assisting patients in performing the SUPPORT exercises as outlined in the program. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Age 18 years or older
- Able to converse in English
- A response of at least "somewhat bothered" by urinary incontinence, urinary frequency or urgency on the UDI
- Willing to engage in conservative treatment of their UI/LUTS for 16 weeks
Key exclusion criteria (6 listed)
- Anterior or posterior pelvic organ prolapse beyond the hymen or apical prolapse to the hymen
- Currently taking medications for their UI/LUTS or history of surgical intervention for UI
- Patients with abnormal PVR and positive urine culture at time of study entry
- History of recurrent UTIs
- History of mobility or neurologic disorders that would prevent ability to complete at home physical therapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SUPPORT workbookAlso: cognitive behavior therapyThe SUPPORT workbook contains a template for how pelvic floor physical therapy is delivered in the typical in-person setting with a combination of education, bladder re-training exercises, pelvic floor stretching and core strengthening. To aid in the demonstration of physical therapy exercises, the workbook includes QR-coded links to videos of a physical therapist performing the exercises in an ideal form. The videos include audio instruction to ensure that patients can learn the concepts in either visual, auditory or written form. The cognitive behavioral therapy (CBT) portion of the workbook is adapted from the standardized CBT protocol and includes short introductions and exercises pertaining to cognitive flexibility, behavioral activation and social support. The total time commitment for the program is 2-hours per week. Patients also will be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques. | Behavioural | SUPPORT workbook |
Primary outcome
Urinary Symptom Changes (UDI Subscale)
Time frame: From enrollment to the end of treatment at 8 weeks
To compare changes in urinary symptoms using the validated Urinary Distress Inventory (UDI) subscale of the Pelvic Floor Distress Inventory (PFDI) between baseline and 8-weeks (program completion) in patients undergoing the SUPPORT program. The Urinary Distress Inventory (UDI-6) is a validated 6-item questionnaire that assesses lower urinary tract symptoms, including incontinence, in women. The UDI-6 score is calculated by averaging the responses to each question (possible value 0 to 4), then multiplying that average by 25 to scale the score from 0 to 100. A higher score indicates greater distress.
9 secondary outcomes
Urinary symptoms - UDI-6 (16 Weeks)
Time frame: From enrollment to 16 weeks after SUPPORT program initiation
Urinary symptoms - LURN SI-10 (16 Weeks)
Time frame: From enrollment to 16 weeks after SUPPORT program initiation
Patient Global Impression of Improvement (PGI-I)
Time frame: From enrollment to 16 weeks after SUPPORT program initiation
Pelvic Organ prolapse Distress Inventory and Colorectal-Anal distress Inventory subscales
Time frame: From enrollment to 16 weeks after SUPPORT program initiation
Adherence
Time frame: From enrollment to 16 weeks after SUPPORT program initiation
Patient Satisfaction with the SUPPORT Program
Time frame: From enrollment to 16 weeks after SUPPORT program initiation
PROMIS-57 - Patient Reported Outcomes Measurement Information System
Time frame: From enrollment to 16 weeks after SUPPORT program initiation
Large Language Model usability (SUS - the System Usability Scale)
Time frame: From enrollment to the end of treatment at 8 weeks
Attitudes toward Large Language Model Use (WAI-TECH-SF - Working Alliance Inventory for Online Interventions-Short Form)
Time frame: From enrollment to the end of treatment at 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Apr 2026.
- Background: PubMed 28145917Zoorob D, Higgins M, Swan K, Cummings J, Dominguez S, Carey E. Barriers to Pelvic Floor Physical Therapy Regarding Treatment of High-Tone Pelvic Floor Dysfunction. Female Pelvic Med Reconstr Surg. 2017 Nov/Dec;23(6):444-448. doi: 10.1097/SPV.0000000000000401.
- Background: PubMed 36516655Clason C, Sterner-Stein K, Hirschman KB, Barg FK, Riegel B. Developing effective health coaches: Experience gained in a clinical trial of a health coach intervention. Patient Educ Couns. 2023 Mar;108:107592. doi: 10.1016/j.pec.2022.107592. Epub 2022 Dec 9.
- Background: PubMed 39036525Al-Anezi FM. Exploring the use of ChatGPT as a virtual health coach for chronic disease management. Learn Health Syst. 2024 Jan 11;8(3):e10406. doi: 10.1002/lrh2.10406. eCollection 2024 Jul.
- Background: PubMed 38564502Hegde N, Vardhan M, Nathani D, Rosenzweig E, Speed C, Karthikesalingam A, Seneviratne M. Infusing behavior science into large language models for activity coaching. PLOS Digit Health. 2024 Apr 2;3(4):e0000431. doi: 10.1371/journal.pdig.0000431. eCollection 2024 Apr.
- Background: PubMed 38609507Stade EC, Stirman SW, Ungar LH, Boland CL, Schwartz HA, Yaden DB, Sedoc J, DeRubeis RJ, Willer R, Eichstaedt JC. Large language models could change the future of behavioral healthcare: a proposal for responsible development and evaluation. Npj Ment Health Res. 2024 Apr 2;3(1):12. doi: 10.1038/s44184-024-00056-z.
- Background: PubMed 24463674Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014 Jan;123(1):141-148. doi: 10.1097/AOG.0000000000000057.
- Background: PubMed 31860569Yazdany T, Jakus-Waldman S, Jeppson PC, Schimpf MO, Yurteri-Kaplan LA, Ferzandi TR, Weber-LeBrun E, Knoepp L, Mamik M, Viswanathan M, Ward RM; American Urogynecologic Society. American Urogynecologic Society Systematic Review: The Impact of Weight Loss Intervention on Lower Urinary Tract Symptoms and Urinary Incontinence in Overweight and Obese Women. Female Pelvic Med Reconstr Surg. 2020 Jan/Feb;26(1):16-29. doi: 10.1097/SPV.0000000000000802.
- Background: PubMed 31045618Woodburn KL, Tran MC, Casas-Puig V, Ninivaggio CS, Ferrando CA. Compliance With Pelvic Floor Physical Therapy in Patients Diagnosed With High-Tone Pelvic Floor Disorders. Female Pelvic Med Reconstr Surg. 2021 Feb 1;27(2):94-97. doi: 10.1097/SPV.0000000000000732.
- Background: PubMed 31526791Sigurdardottir T, Steingrimsdottir T, Geirsson RT, Halldorsson TI, Aspelund T, Bo K. Can postpartum pelvic floor muscle training reduce urinary and anal incontinence?: An assessor-blinded randomized controlled trial. Am J Obstet Gynecol. 2020 Mar;222(3):247.e1-247.e8. doi: 10.1016/j.ajog.2019.09.011. Epub 2019 Sep 14.
- Background: PubMed 27171320Siddiqui NY, Ammarell N, Wu JM, Sandoval JS, Bosworth HB. Urinary Incontinence and Health-Seeking Behavior Among White, Black, and Latina Women. Female Pelvic Med Reconstr Surg. 2016 Sep-Oct;22(5):340-5. doi: 10.1097/SPV.0000000000000286.
- Background: PubMed 15572487Segal JL, Vassallo B, Kleeman S, Silva WA, Karram MM. Prevalence of persistent and de novo overactive bladder symptoms after the tension-free vaginal tape. Obstet Gynecol. 2004 Dec;104(6):1263-9. doi: 10.1097/01.AOG.0000147596.44421.72.
- Background: PubMed 19842866Rhodes RE, Fiala B. Building motivation and sustainability into the prescription and recommendations for physical activity and exercise therapy: the evidence. Physiother Theory Pract. 2009 Jul;25(5-6):424-41. doi: 10.1080/09593980902835344.
- Individual participant dataSharing planned: No
Related trials for Urinary Incontinence (UI)
Active, not recruitingObservational study
Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis
Rheumatoid Arthritis, Rheumatoid Arthritis (RA)
Not yet recruitingObservational study
Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response
Urinary Incontinence (UI)
Recruiting
Ambulatory Long Length URodynamics Evaluation
Urology, Urinary Bladder, Overactive
Recruiting
Comparing the Effect of Two Types of Pelvic Floor Muscle Stimulation Devices to Improve Symptoms of Urinary Incontinence in Women.
Urinary Incontinence, Mixed Urinary Incontinence
Not yet recruiting
Transcutaneous Tibial Nerve Stimulation for Urinary Incontinence After Radical Prostatectomy
Urinary Incontinence (UI), Prostatectomy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kimberly Kenton, MD principal investigator
University of Chicago
James Griffith, PhD principal investigator
University of Chicago
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SUPPORT workbook in people with Urinary Incontinence (UI) and Lower Urinary Tract Symptoms (LUTS), run by University of Chicago at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jinxuan (Rowena) Shi, MA (773-795-2731, jinxuan.shi@bsd.uchicago.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Urinary Symptom Changes (UDI Subscale) (time frame: From enrollment to the end of treatment at 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06798311, which also lists 25 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.